Monitoring of COVID-19 vaccination in pregnant women of Siberia and the Russian Far East


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Objective: To evaluate the dynamics of vaccination against the new coronavirus infection COVID-19 in pregnant women in the Far Eastern and Siberian Federal Districts from October 29, 2021 to December 24, 2021. Materials and methods: A total of 127787 pregnant women were monitored for vaccination from October 29, 2021 to December 24, 2021 in 11 regions of the Far Eastern Federal District and 10 regions of the Siberian Federal District. The findings were presented by the chief obstetricians-gynecologists of the regions. Statistical processing of the obtained data was carried out using the software package Microsoft Excel 2007. The level of null hypothesis testing was considered to be statistically significant atp<0.05. Results: According to the presented data, 126897pregnant women were registered in the regions of the Far East and Siberia as of October 29, 2021, and 127787women as of December 24, 2021. The results of the study showed an extremely low percentage of preconception specific prevention in pregnant women in the Far East and Siberia as of October 29, 2021. This indicator increased within two months by more than 2.26 times, namely from 4.2% to 9.5%. During monitoring, the proportion of vaccinated women before 22 weeks gestation increased by 2.1 times, from 0.7 to 1.5%; after 22 weeks gestation, it increased by 3.7 times, from 1.5 to 5.5%. The proportion of pregnant women who were ill with COVID-19 or vaccinated in the regions of the Far Eastern and Siberian Federal Districts increased from 13.0% to 26.3% during the monitoring period (p<0.001). There were no serious adverse events during COVID-19 vaccination with the Gam-COVID-Vac vaccine (Sputnik V) in 9667pregnant women. Conclusion: Despite the absence of serious adverse events during COVID-19 vaccination with the Gam-COVID-Vac (Sputnik V) vaccine in pregnant women, it is necessary to conduct further detailed studies of the safety of vaccination during pregnancy, and also to develop a set of organizational measures aimed at increasing compliance with vaccination against COVID-19 at the period of pregnancy planning.

Full Text

Restricted Access

About the authors

Natalya V. Artymuk

Kemerovo State Medical University, Ministry of Health of Russia

Email: artymuk@gmail.com
MD, PhD, Professor, Head of the G.A. Ushakova Department of Obstetrics and Gynecology

Tatiana E. Belokrinitskaya

Chita State Medical Academy, Ministry of Health of Russia

Email: tanbell24@mail.ru
MD, PhD, Professor, Head of the Department of Obstetrics and Gynecology

Yana A. Parfenova

Kemerovo State Medical University, Ministry of Health of Russia

Email: titova@list.ru
MD, postgraduate student of the G.A. Ushakova Department of Obstetrics and Gynecology

Nataly I. Frolova

Chita State Medical Academy, Ministry of Health of Russia

Email: taasyaa@mail.ru
MD, PhD, Associate Professor at the Department of Obstetrics and Gynecology, Pediatric Faculty, Faculty of Continuing Education and Professional Retraining

References

  1. Jamieson D.J., Rasmussen S.A. An update on COVID-19 and pregnancy. Am. J. Obstet. Gynecol. 2022; 226(2):177-86. https://dx.doi.org/10.1016/j.ajog.2021.08.054.
  2. Dashraath P., Wong J.L.J., Lim M.X.K., Lim L.M., Li S., Biswas A. et al. Coronavirus disease 2019 (COVID-19) pandemic and pregnancy. Am. J. Obstet. Gynecol. 2020; 222(6): 521-31. https://dx.doi.org/10.1016/j.ajog.2020.03.021.
  3. Белокриницкая Т.Е., Артымук Н.В., Филиппов О.С., Фролова Н.И. Клиническое течение, материнские и перинатальные исходы новой коронавирусной инфекции COVID-19 у беременных Сибири и Дальнего Востока. Акушерство и гинекология. 2021; 2: 48-54. https://dx.doi.org/10.18565/aig.2021.2.48-54.
  4. Artymuk N.V., Belokrinitskaya T.E., Filippov O.S., Frolova N.I., Surina M.N. Perinatal outcomes in pregnant women with COVID-19 in Siberia and the Russian Far East. J. Matern. Fetal Neonatal Med. 2021; Feb 2: 1-4. https://dx.doi.org/10.1080/14767058.2021.1881954.
  5. Westgren M., Pettersson K., Hagberg H., Acharya G. Severe maternal morbidity and mortality associated with COVID-19: The risk should not be downplayed. Acta Obstet. Gynecol. Scand. 2020; 99(7): 815-6. https://dx.doi.org/10.1111/aogs.13900.
  6. Collin J., Bystrom E., Carnahan A., Ahrne M. Public Health Agency of Sweden's Brief Report: Pregnant and postpartum women with severe acute respiratory syndrome coronavirus 2 infection in intensive care in Sweden. Acta Obstet. Gynecol. Scand. 2020; 99(7): 819-22. https://dx.doi.org/10.1111/aogs.13901.
  7. Vallejo V., Ilagan J.G. A Postpartum death due to coronavirus disease 2019 (COVID-19) in the United States. Obstet. Gynecol. 2020; 136(1): 52-5. https://dx.doi.org/10.1097/AOG.0000000000003950.
  8. Jafari M., Pormohammad A., Sheikh Neshin S.A., Ghorbani S., Bose D. Clinical characteristics and outcomes of pregnant women with COVID-19 and comparison with control patients: A systematic review and meta-analysis. Rev. Med. Virol. 2021; 31(5): 1-16. https://dx.doi.org/10.1002/rmv.2208.
  9. Di Toro F., Gjoka M., Di Lorenzo G., De Santo D., De Seta F. Impact of COVID-19 on maternal and neonatal outcomes: a systematic review and metaanalysis. Clin. Microbiol. Infect. 2021; 27(1): 36-46. https://dx.doi.org/10.1016/j.cmi.2020.10.007.
  10. Centers for Disease Control and Prevention. Interim clinical considerations for use of COVID-19 vaccines currently approved or authorized in the United States. 2021. Available at: https://www.cdc.gov/vaccines/covid-19/clinical-considerations/covid-19-vaccines-us.html#pregnant Accessed October 15, 2021.
  11. COVID RCOG 19 vaccines, pregnancy and breastfeeding. 2021. Available at: https://www.rcog.org.uk/en/guidelines-research-services/coronavirus-covid-19-pregnancy-and-womens-health/covid-19-vaccines-and-pregnancy/ covid-19-vaccines-pregnancy-and-breastfeeding/ Accessed October 15, 2021.
  12. Razzaghi H., Meghani M., Pingali C., Crane B., Naleway A., Weintraub E. et al. COVID-19 vaccination coverage among pregnant women during pregnancy-eight integrated health care organizations, United States, December 14, 2020-May 8, 2021. MMWR Morb. Mortal Wkly Rep. 2021; 70(24): 895-9. https://dx.doi.org/10.15585/mmwr.mm7024e2.
  13. Centers for Disease Control and Prevention. V-safe COVID-19 vaccine pregnancy registry. 2021. Available at: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety/vsafepregnancyregistry.html Accessed October 15, 2021.
  14. American College of Obstetricians and Gynecologists COVID-19 vaccination considerations for obstetric-gynecologic care. Practice advisory. 2020. Available at: https://www.acog.org/clinical/clinical-guidance/ practice-advisory/articles/2020/12/covid-19-vaccination-considerations-for-obstetric-gynecologic-care Accessed October 15, 2021.
  15. RANZCOG, COVID-19 Vaccination in Pregnant and Breastfeeding Women. Updated Wednesday 10 March 2021. Available at: https://ranzcog.edu.au/statementsguidelines/covid-19-statement/covid-19-vaccination-information
  16. Rasmussen S.A., Kelley C.F., Horton J.P., Jamieson D.J. Coronavirus disease 2019 (COVID-19) vaccines and pregnancy: what obstetricians need to know. Obstet. Gynecol. 2021; 137(3): 408-14. https://dx.doi.org/10.1097/ AOG.0000000000004290.
  17. Сухих Г.Т., Долгушина Н.В., Шмаков Р.Г., Климов В.А., Яроцкая Е.Л. Исходы беременности у пациенток, вакцинированных от COVID-19 во время беременности: предварительные данные. Акушерство и гинекология. 2021; 11: 5-8. https://dx.doi.org/10.18565/aig.2021.11.5-8.
  18. Министерство здравоохранения Российской Федерации. Временные методические рекомендации «Организация оказания медицинской помощи беременным, роженицам, родильницам и новорожденным при новой коронавирусной инфекции COVID-19». Версия 4 (01.07.2021). Доступно по: https://static-0.minzdrav.gov.ru/system/attachments/attaches/000/057/333/original/05072021_MR_Preg_v4.pdf Ссылка активна на 08.01.2022.
  19. Blumberg D., Sridhar A., Lakshminrusimha S., Higgins R.D., Saade G. COVID-19 vaccine considerations during pregnancy and lactation. Am. J. Perinatol. 2021; 38(6): 523-8. https://dx.doi.org/10.1055/s-0041-1726390.
  20. Shimabukuro T.T., Kim S.Y., Myers T.R., Moro P.L., Odoyebo T., Panagiotakopoulos L. et al. Preliminary findings of mRNA Covid-19 vaccine safety in pregnant persons. N. Engl. J. Med. 2021; 384(24): 2273-82. https://dx.doi.org/10.1056/NEJMoa2104983.
  21. MacNeil J.R., Su J.R., Broder K.R., Guh A.Y., Gargano J.W., Wallace M. et al. Updated recommendations from the Advisory Committee on Immunization Practices for use of the Janssen (Johnson & Johnson) COVID-19 vaccine after reports of thrombosis with thrombocytopenia syndrome among vaccine recipients-United States, April 2021. MMWR Morb. Mortal Wkly Rep. 2021; 70(17): 651-6. https://dx.doi.org/10.15585/mmwr.mm7017e4.
  22. MacIntyre C.R., Veness B., Berger D., Hamad N., Bari N. Thrombosis with thrombocytopenia syndrome (TTS) following AstraZeneca ChAdOx1 nCoV-19 (AZD1222) COVID-19 vaccination - a risk-benefit analysis for people № 60 years in Australia. Vaccine. 2021; 39(34): 4784-7. https://dx.doi.org/10.1016/j.vaccine.2021.07.013.
  23. American College of Obstetricians and Gynecologists COVID-19 vaccination considerations for obstetric-gynecologic care. Practice advisory. 2020. Available at: https://www.acog.org/clinical/clinical-guidance/practice-advisory/articles/2020/12/covid-19-vaccination-considerations-for-obstetric-gynecologic-care Accessed October 15, 2021.
  24. Шипицына Е.В., Ширшова Н.Ю., Коган И.Ю. Вакцинация во время беременности: настоящее и будущее. Акушерство и гинекология. 2021; 11: 9-16. [Shipitsyna E.V., Shirshova N.Y., Kogan I.Y. Vaccination during pregnancy: present and future. Akusherstvo i ginekologiya/ Obstetrics and Gynecology. 2021; 11: 9-16 (in Russian)]. https://dx.doi.org/10.18565/aig.2021.11.9-16.
  25. Министерство здравоохранения Российской Федерации. Временные методические рекомендации «Организация оказания медицинской помощи беременным, роженицам, родильницам и новорожденным при новой коронавирусной инфекции COVID-19». Версия 5 (28.12.2021) Доступно по: https://static-0.minzdrav.gov.ru/system/attachments/attaches/000/059/052/original/BMP_preg_5.pdf Ссылка активна на: 08.01.2022.
  26. Долгушина Н.В., Драпкина Ю.С., Кречетова Л.В., Иванец Т.Ю., Менжинская И.В., Гус А.И., Байрамова Г.Р., Сухих Г. Т. Вакцина Гам-КОВИД-Вак (Спутник V) не оказывает негативного влияния на овариальный резерв у женщин репродуктивного возраста. Акушерство и гинекология. 2021; 7: 81-6. https://dx.doi.org/10.18565/aig.2021.7.81-86.
  27. Драпкина Ю.С., Долгушина Н.В., Шатылко Т.В., Николаева М.А., Менжинская И.В., Иванец Т.Ю., Кречетова Л.В., Красный А.М., Гамидов С.И., Байрамова Г.Р., Сухих Г. Т. Вакцина Гам-КОВИД-Вак (Спутник V) не оказывает негативного влияния на сперматогенез у мужчин. Акушерство и гинекология. 2021; 7: 88-94.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies